BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $157,333,808 | +20.9% | 1,459,484 | +6.4% | 0.01% | +16.7% |
Q1 2024 | $130,084,109 | +6.2% | 1,371,127 | +3.3% | 0.01% | -7.7% |
Q4 2023 | $122,440,095 | +92.5% | 1,327,256 | +4.8% | 0.01% | +62.5% |
Q3 2023 | $63,611,395 | -17.6% | 1,266,497 | +3.7% | 0.01% | -11.1% |
Q2 2023 | $77,179,418 | +47.6% | 1,221,193 | +5.0% | 0.01% | +28.6% |
Q1 2023 | $52,307,189 | +107045.1% | 1,162,640 | +4.3% | 0.01% | 0.0% |
Q4 2022 | $48,819 | -99.9% | 1,114,337 | +3.6% | 0.01% | -36.4% |
Q3 2022 | $70,851,000 | +33.7% | 1,075,293 | +2.5% | 0.01% | +37.5% |
Q2 2022 | $52,982,000 | -20.0% | 1,048,949 | +1.2% | 0.01% | 0.0% |
Q1 2022 | $66,218,000 | -40.0% | 1,036,608 | +0.6% | 0.01% | -38.5% |
Q4 2021 | $110,315,000 | +5.9% | 1,029,931 | +1.7% | 0.01% | -7.1% |
Q3 2021 | $104,151,000 | +15.8% | 1,013,050 | -0.9% | 0.01% | +16.7% |
Q2 2021 | $89,912,000 | -4.3% | 1,022,201 | +5.8% | 0.01% | -14.3% |
Q1 2021 | $93,972,000 | -3.2% | 966,496 | +11.6% | 0.01% | -12.5% |
Q4 2020 | $97,117,000 | +27.7% | 865,962 | +5.5% | 0.02% | +6.7% |
Q3 2020 | $76,078,000 | +18.5% | 820,698 | -0.3% | 0.02% | +7.1% |
Q2 2020 | $64,217,000 | +38.4% | 823,304 | +3.7% | 0.01% | +16.7% |
Q1 2020 | $46,409,000 | -58.1% | 793,609 | -42.6% | 0.01% | 0.0% |
Q4 2019 | $110,762,000 | +127.8% | 1,382,636 | +109.0% | 0.01% | +9.1% |
Q3 2019 | $48,615,000 | -21.1% | 661,706 | +1.3% | 0.01% | -26.7% |
Q2 2019 | $61,628,000 | +43.4% | 653,327 | +21.7% | 0.02% | +36.4% |
Q1 2019 | $42,980,000 | -19.1% | 536,923 | -45.5% | 0.01% | +37.5% |
Q4 2018 | $53,118,000 | +47.2% | 985,324 | +113.2% | 0.01% | -20.0% |
Q3 2018 | $36,076,000 | +39.4% | 462,163 | +13.3% | 0.01% | +25.0% |
Q2 2018 | $25,887,000 | -25.0% | 407,811 | +8.3% | 0.01% | -27.3% |
Q1 2018 | $34,515,000 | +23.9% | 376,396 | +1.9% | 0.01% | +22.2% |
Q4 2017 | $27,855,000 | +19.7% | 369,391 | +10.6% | 0.01% | 0.0% |
Q3 2017 | $23,265,000 | +45.3% | 333,936 | +5.6% | 0.01% | +50.0% |
Q2 2017 | $16,016,000 | +57.7% | 316,092 | +24.4% | 0.01% | +50.0% |
Q1 2017 | $10,158,000 | +58.9% | 254,026 | +11.5% | 0.00% | +33.3% |
Q4 2016 | $6,392,000 | +26.8% | 227,898 | +34.3% | 0.00% | 0.0% |
Q3 2016 | $5,040,000 | +158.3% | 169,729 | +76.1% | 0.00% | +200.0% |
Q2 2016 | $1,951,000 | +50.5% | 96,381 | +34.2% | 0.00% | 0.0% |
Q1 2016 | $1,296,000 | -29.5% | 71,813 | +2.9% | 0.00% | 0.0% |
Q4 2015 | $1,838,000 | +26.5% | 69,802 | +2.5% | 0.00% | 0.0% |
Q3 2015 | $1,453,000 | – | 68,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |